Clinical Trial Update: Randomized, Double Blind, Multicenter Study of the Safety and Efficacy of Valdecoxib 40 mg Once Daily Compared With Diclofenac 75 mg Twice Daily in Acute Low Back Pain [Phase 4]

View source ↗

Summary

A randomized, double-blind, multicenter phase 4 trial comparing Valdecoxib 40 mg daily with Diclofenac 75 mg twice daily to assess safety and efficacy in adults…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain

Drugs mentioned

• Diclofenac (diclofenac)
• Valdecoxib (valdecoxib)

Snippet

Sponsor: Pfizer | Conditions: Low Back Pain | Phase 4 | Status: COMPLETED